Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
0,2058 USD | -19,89% |
|
-2,00% | -69,15% |
Attività
Numero di dipendenti: 21
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Ken Berlin
CEO | Chief Executive Officer | 59 | 01/04/18 |
Shmuel Tuvia
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/22 |
General Counsel | - | 01/01/18 | |
Human Resources Officer | - | 01/01/19 | |
Dana Gelbaum
PRN | Corporate Officer/Principal | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
David Sidransky
CHM | Chairman | 64 | 01/11/17 |
Roni Appel
BRD | Director/Board Member | 57 | 01/11/04 |
Murray Goldberg
BRD | Director/Board Member | 79 | 01/12/17 |
Robert Spiegel
BRD | Director/Board Member | 73 | 01/12/17 |
Pini Orbach
BRD | Director/Board Member | - | 19/10/23 |
Ken Berlin
CEO | Chief Executive Officer | 59 | 01/04/18 |
Director/Board Member | 53 | 01/08/20 | |
Yuval Cabilly
BRD | Director/Board Member | 44 | 19/10/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 42 672 852 | 42 632 797 ( 99,91 %) | 39 452 ( 0,0925 %) | 99,91 % |
Coordinate società
Ayala Pharmaceuticals, Inc.
9 Deer Park Drive Suite K-1
08852, Monmouth Junction
+
http://www.ayalapharma.com![Indirizzo Ayala Pharmaceuticals, Inc.(ADXS)](https://cdn.zonebourse.com/static/address/56593690.png)
Settore
![Consenso](/images/consensus_flch.gif)
Chiffre d''affaires - Indice di sorpresa
Variaz. 1 gen. | Capi. | |
---|---|---|
-69,15% | 10,15 Mln | |
+17,72% | 44,87 Mrd | |
-10,33% | 37,8 Mrd | |
+42,32% | 37,61 Mrd | |
+29,36% | 31,32 Mrd | |
-8,44% | 27,4 Mrd | |
+12,45% | 26,32 Mrd | |
+44,19% | 14,07 Mrd | |
+31,93% | 12,5 Mrd | |
-7,67% | 11,23 Mrd |
- Borsa valori
- Azioni
- Azione ADXS
- Società Ayala Pharmaceuticals, Inc.